MANNITOL INJECTION USP 20 %
MANNITOL : 20 % · DIN 00038016 · ICU MEDICAL CANADA INC
Health Canada status: MARKETED
What is MANNITOL INJECTION USP?
MANNITOL INJECTION USP 20 % contains MANNITOL : 20 %. It is listed in the Health Canada Drug Product Database under DIN 00038016, held by ICU MEDICAL CANADA INC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 05-Mar-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00038016 |
|---|---|
| Brand name | MANNITOL INJECTION USP |
| Generic / active ingredient | MANNITOL : 20 % |
| Manufacturer | ICU MEDICAL CANADA INC |
| Strength | 20 % |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05BC01 MANNITOL |
| AHFS class | 40:28.12 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 05-Mar-2020 |
| Original market date | 1970-12-31 00:00:00 |
Is MANNITOL in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by PFIZER CANADA ULC, last seen 10 Aug 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code B05BC01 MANNITOL. 5 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MANNITOL INJECTION USP | 25 % | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00038024 |
| MANNITOL INJECTION, USP | 25 % | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02243176 |
| OSMITROL INJECTION 10% | 10 % | SOLUTION | BAXTER CORPORATION | MARKETED | DIN 00060410 |
| OSMITROL INJECTION 20% | 20 % | SOLUTION | BAXTER CORPORATION | MARKETED | DIN 00060437 |
| MANNITOL INJ 10% ABBOVAC | 100 MG | LIQUID | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 00037990 |
| MANNITOL INJ 25% | 250 MG | LIQUID | INTERNATIONAL MEDICATION SYSTEMS LTD. | CANCELLED POST MARKET | DIN 00243809 |
| MANNITOL INJ 25% | 250 MG | LIQUID | ASTRA PHARMA INC. | CANCELLED POST MARKET | DIN 00729183 |
| MANNITOL INJ 5% ABBOVAC | 50 MG | LIQUID | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 00037982 |
Who else supplies MANNITOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MANNITOL appears in 72 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.